METHOD OF ANESTHESIA IN SURGICAL INTERVENTIONS OF PHEOCHROMOCYTOMA PATIENTS

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, namely, anesthesiology and u0440u0435u0430u043du0438u043cu0430u0442u043eu043bu043eu0433u0438u0438. the objective is to reduce the complications u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u0432u043du0443u0442u0440u0438u043eu043fu0435u0440u0430u0446u0438u043eu043du043du043eu0433u043e period by preventing the vascular kriesow patients with operational interventions on the fe u043eu0445u0440u043eu043cu043eu0446u0438u0442u043eu043cu044b.the purpose of u0434u043eu0441u0442u0438u0433u0430u0435u0442u0441u00a0 by puncture and epidural space at the level of cath and 9 - 10, u0432u0432u0435u0434u0435u043du0438u00a0 test doses of 50 mg of 1% solution of u0442u0440u0438u043cu0435u043au0430u0438u043du0430 and u043eu0442u0441u0443u0442u0441u0442u0432 and negative reactions u0432u0432u0435u0434u0435u043du0438u00a0 solution u0442u0440u0438u043cu0435u043au0430u0438u043du0430 at 1.5 mg / kg of the patient.after u043du0430u0441u0442u0443u043fu043bu0435u043du0438u00a0 sympathetic blockade in 25 to 30 min u043eu0441u0443u0449u0435u0441u0442u0432u043bu00a0u044eu0442 u043eu0431u0449u0435u043fu0440u0438u043du00a0u0442u0443u044e induction anesthesia, tracheal intubation, artificial u0432u0435u043du0442u0438u043bu00a0u0446u0438u044e light, primary and u043du0435u0441u0442u0435u0437u0438u044e drugs u0434u043bu00a0 u043du0435u0439u0440u043eu043bu0435u043fu0442u0430u043du0430u043bu0433u0435u0437u0438u0438. before starting the operation again u0432u0432u043eu0434u00a0u0442 in epidural space 1% solution u0442u0440u0438u043cu0435u043au0430u0438u043du0430 at the dose of 1.5 mg / kg of body weight.the u0430u043du0435u0441u0442u0435u0437u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au043eu0435 ensuring u043fu043eu0437u0432u043eu043bu00a0u0435u0442 warn expression u0438u0437u043cu0435u043du0435u043du0438u00a0 indicators of hemodynamics in u0432u0440u0435u043cu00a0 operation, reduce complications. 2, table 2).